Aimee Iberg

Aimee Iberg is a seasoned professional in oncology drug discovery and translational research, currently serving as Senior Director of Oncology Industrialized Drug Discovery at Recursion since March 2022. Previous roles include Senior Director of In Vitro Pharmacology R&D at Molecular Templates and Director of Discovery at Shattuck Labs. Iberg has extensive experience in managing preclinical discovery projects and cross-functional collaboration. Academic credentials include a Ph.D. in Molecular Carcinogenesis from The University of Texas Health Science Center at Houston and a B.S. in Chemical Engineering from The University of Texas at Austin. Additional past experiences include research and consulting roles in various organizations, including Stanford University, Harvard Medical School, and MD Anderson Cancer Center.